{"id":"NCT01492426","sponsor":"Bristol-Myers Squibb","briefTitle":"Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection","officialTitle":"A Phase 3 Evaluation of BMS-790052 (Daclatasvir) Compared With Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Patients With Chronic Hepatitis C","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-01","primaryCompletion":"2013-12","completion":"2014-03","firstPosted":"2011-12-15","resultsPosted":"2016-06-03","lastUpdate":"2016-06-03"},"enrollment":605,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hepatitis C"],"interventions":[{"type":"DRUG","name":"Daclatasvir","otherNames":["BMS-790052"]},{"type":"DRUG","name":"Telaprevir","otherNames":["Incivek®"]},{"type":"DRUG","name":"Peginterferon alfa-2a","otherNames":["Pegasys®"]},{"type":"DRUG","name":"Ribavirin","otherNames":["Copegus®"]}],"arms":[{"label":"Daclatasvir + Peginterferon alfa-2a + Ribavirin","type":"EXPERIMENTAL"},{"label":"Telaprevir + Peginterferon alfa-2a + Ribavirin","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to compare the effectiveness of BMS-790052 (Daclatasvir) and Telaprevir when given in combination with Peginterferon alfa-2a and Ribavirin in genotype 1b patients","primaryOutcome":{"measure":"Percentage of Genotype 1b Participants With Sustained Virologic Response at Follow-up Week 12 (SVR12)","timeFrame":"Week 12 (Follow-up period)","effectByArm":[{"arm":"Daclatasvir + PEG-IFN Alpha-2a + Ribavirin","deltaMin":85.1,"sd":null},{"arm":"Telaprevir + PEG-IFN Alpha-2a + Ribavirin","deltaMin":81.3,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":2},"locations":{"siteCount":91,"countries":["United States","Argentina","Australia","Austria","Brazil","Canada","Denmark","France","Germany","Israel","Italy","Poland","Russia","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":[],"seeAlso":["http://www.bms.com/studyconnect/Pages/home.aspx","http://www.bms.com/clinical_trials/Pages/Investigator_Inquiry_form.aspx"]},"adverseEventsSummary":{"seriousAny":{"events":26,"n":402},"commonTop":["Fatigue","Anaemia","Headache","Pruritus","Rash"]}}